Even as public opinion shifts in favor of marijuana legalization, with sixty percent of Americans supporting broad legalization and ninety percent supporting medical use, Attorney General Jeff Sessions and the Department of Justice (DOJ) continue to stonewall efforts to expand availability of cannabis and cannabis-derived treatments for medical research.
In testimony to a Senate Appropriations subcommittee in April, Sessions argued that although recent studies have shown that access to medical marijuana reduces opioid overdose deaths, the evidence to support expanding access is still insufficient.
This is simply untrue. While DOJ and DEA policy have limited the ability of U.S. researchers to access and experiment with medical grade marijuana, substantial peer-reviewed scientific research supports the benefits of medical marijuana.
Medical marijuana has been shown to improve the quality of life and health outcomes of patients with cancer, multiple sclerosis, Parkinson’s disease, chronic